New diabetes clinical trial: Anti-TNFα to Delay or Prevent Progression to Stage 3 T1D
Published on: January 28, 2021 at 10:30PM
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Golimumab; Drug: Placebo
Sponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of South Florida
Not yet recruiting
https://ift.tt/2YoSLGo
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Golimumab; Drug: Placebo
Sponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of South Florida
Not yet recruiting
https://ift.tt/2YoSLGo
Comments
Post a Comment